ARG1 Protein

Migration, Crosslink

📖

ARG1 Protein

active

wiki page Created: 2026-04-02T07:19:09 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-arg1-protein

📖 Wiki Page

protein1300 wordssynced 2026-04-02

ARG1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ARG1 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Arginase-1</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[ARG1](/genes/arg1)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P05089](https://www.uniprot.org/uniprot/P05089)</td>
</tr>
<tr>
<td class="label">PDB ID</td>
<td>[1HQ8](https://www.rcsb.org/structure/1HQ8), [4HVW](https://www.rcsb.org/structure/4HVW)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~35 kDa (homotrimer: ~105 kDa)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Arginase family (metallohydrolase)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Liver, erythrocytes, brain ([astrocytes](/entities/astrocytes), [microglia](/cell-types/microglia-neuroinflammation), neurons)</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">NOS1/nNOS</td>
<td>Substrate competition</td>
</tr>
<tr>
<td class="label">[ODC1](/genes/odc1)</td>
<td>Metabolic pathway</td>
</tr>
<tr>
<td class="label">[GLS1](/genes/gls1)</td>
<td>Metabolic connection</td>
</tr>
<tr>
<td class="label">[GFAP](/genes/gfap)</td>
<td>Cell type expression</td>
</tr>
<tr>
<td class="label">[CD206](/genes/mrc1)</td>

...

ARG1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ARG1 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Arginase-1</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[ARG1](/genes/arg1)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P05089](https://www.uniprot.org/uniprot/P05089)</td>
</tr>
<tr>
<td class="label">PDB ID</td>
<td>[1HQ8](https://www.rcsb.org/structure/1HQ8), [4HVW](https://www.rcsb.org/structure/4HVW)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~35 kDa (homotrimer: ~105 kDa)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Arginase family (metallohydrolase)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Liver, erythrocytes, brain ([astrocytes](/entities/astrocytes), [microglia](/cell-types/microglia-neuroinflammation), neurons)</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">NOS1/nNOS</td>
<td>Substrate competition</td>
</tr>
<tr>
<td class="label">[ODC1](/genes/odc1)</td>
<td>Metabolic pathway</td>
</tr>
<tr>
<td class="label">[GLS1](/genes/gls1)</td>
<td>Metabolic connection</td>
</tr>
<tr>
<td class="label">[GFAP](/genes/gfap)</td>
<td>Cell type expression</td>
</tr>
<tr>
<td class="label">[CD206](/genes/mrc1)</td>
<td>Co-expression</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">106 edges</a></td>
</tr>
</table>

Arginase-1 (ARG1) is a cytosolic metalloenzyme that catalyzes the hydrolysis of L-arginine to L-ornithine and urea, representing the final step of the urea cycle. While traditionally studied in the liver for its role in ammonia detoxification, arginase-1 has emerged as a critical regulator of various physiological and pathological processes in the nervous system. In the brain, ARG1 plays dual roles—一方面参与正常的神经功能调节，另一方面在神经退行性疾病中发挥复杂的病理作用. [@structural2021]

Protein Overview

Structure

Primary Structure

ARG1 is a 322-amino acid protein that forms a homotrimeric complex. Each monomer contains: [@polyamines2022a]

N-terminal region: Involved in trimerization and substrate binding
Active site: Contains two manganese ions (Mn²⁺) coordinated by aspartate and histidine residues
C-terminal domain: Contributes to oligomerization interface

Three-Dimensional Structure

The crystal structure of ARG1 reveals a trimeric arrangement with three identical active sites. The active site contains the signature motif "DXHXH" (residues 101-104) that coordinates the binuclear manganese cluster essential for catalytic activity [1]. [@polyamine2021]

Structural Features

Metal binding site: Binuclear Mn²⁺ cluster essential for catalytic function
Substrate channel: Narrow entrance restricts access to active site
Allosteric regulation: Slight conformational changes affect enzyme activity

Normal Function in the Nervous System

Urea Cycle in the Brain

While the complete urea cycle is primarily active in the liver, [neurons](/entities/neurons) and astrocytes express key enzymes including ARG1, enabling local arginine metabolism:

Ammonia detoxification: ARG1 in astrocytes helps neutralize ammonia released during neurotransmission and metabolic processes [2]

Ornithine production: Provides substrate for polyamine synthesis and proline biosynthesis

Arginine homeostasis: Regulates local arginine availability for nitric oxide synthesis

Nitric Oxide Regulation

ARG1 directly competes with nitric oxide synthase (NOS) for the common substrate L-arginine:

Substrate competition: By depleting arginine, ARG1 limits NOS activity and NO production [3]

Neuroprotective vs. harmful NO: ARG1-mediated regulation influences the balance between physiological and pathological nitric oxide signaling

Coupled regulation: Arginase and NOS activities are reciprocally regulated in response to cellular signals

Polyamine Synthesis

The L-ornithine produced by ARG1 serves as a precursor for polyamines:

Ornithine decarboxylase (ODC): Converts ornithine to putrescine

Polyamine functions: Spermidine and spermine are essential for:

Synaptic plasticity and memory formation
Neuronal survival and differentiation
Protection against oxidative stress

Immune Regulation

ARG1 is highly expressed in immune cells including microglia and infiltrating monocytes:

M2 polarization: ARG1 is a marker of anti-inflammatory (M2) microglial phenotype [4]

T-cell regulation: Arginase activity suppresses T-cell proliferation and function

Inflammatory resolution: Helps terminate excessive neuroinflammatory responses

Role in Neurodegenerative Diseases

Alzheimer's Disease (AD)

Amyloid Metabolism

APP processing: Arginine availability influences [amyloid precursor protein](/entities/app-protein) (APP) processing and [amyloid-beta](/proteins/amyloid-beta) production [5]
Aβ clearance: Polyamines derived from ARG1 activity may enhance Aβ clearance mechanisms
Neuroinflammation: M1/M2 microglial polarization, with ARG1-expressing M2 cells, affects Aβ clearance efficiency

Tau Pathology

Phosphorylation regulation: Arginine metabolism influences [tau](/proteins/tau) phosphorylation through effects on kinase/phosphatase activities [6]
Neurofibrillary tangles: Ornithine-derived polyamines may interact with tau aggregation pathways

Neurotransmitter Systems

Glutamate homeostasis: ARG1 affects arginase-derived ornithine that can be converted to glutamate
Excitotoxicity: Altered arginine metabolism contributes to glutamate-mediated excitotoxic cell death [7]

Therapeutic Implications

Arginase inhibitors: Being explored as potential AD therapeutics to modulate neuroinflammation
Arginine supplementation: Investigated for enhancing polyamine synthesis and cognitive function [8]

Parkinson's Disease (PD)

Dopaminergic Neuron Survival

Metabolic support: ARG1 provides ornithine for energy metabolism in dopaminergic neurons
Mitochondrial function: Polyamines from ARG1 activity support mitochondrial health and protect against [alpha-synuclein](/proteins/alpha-synuclein) toxicity [9]

Neuroinflammation

Microglial activation: ARG1 expression in microglia correlates with anti-inflammatory responses
Neuroprotection: M2 microglia expressing ARG1 provide support for dopaminergic neuron survival

Levodopa Metabolism

Interaction with L-DOPA: Arginase competes with aromatic amino acid decarboxylase for substrate
Therapeutic implications: Understanding ARG1 may inform combination therapies [10]

Amyotrophic Lateral Sclerosis (ALS)

Motor Neuron Vulnerability

Energy metabolism: ARG1 supports polyamine synthesis crucial for high energy demands of motor neurons
Oxidative stress: Polyamines provide protection against [ROS](/entities/reactive-oxygen-species) in motor neurons [11]

Glial Contributions

Astrocyte dysfunction: Altered arginase expression in astrocytes affects motor neuron support
Microglial polarization: M2 microglia expressing ARG1 may modulate disease progression

Multiple Sclerosis (MS)

Demyelination and Remyelination

Myelin repair: Polyamines promote oligodendrocyte precursor cell (OPC) differentiation
Remyelination enhancement: ARG1 activity supports remyelination processes [12]

Autoimmune Regulation

T-cell suppression: ARG1 activity in myeloid cells suppresses autoreactive T-cell responses
Immunomodulation: Potential therapeutic target for MS treatment

Huntington's Disease (HD)

Polyamine Dysregulation

Elevated polyamines: Altered ARG1 activity contributes to polyamine abnormalities in HD
Neuroprotective effects: Polyamines may offer protection against mutant [huntingtin](/proteins/huntingtin) toxicity [13]

Energy Metabolism

Mitochondrial function: ARG1-derived ornithine supports mitochondrial energy production
Therapeutic targeting: Modulating arginase activity may benefit HD patients

Diagnostic and Biomarker Potential

Cerebrospinal Fluid Biomarkers

ARG1 activity: Measured in CSF as a marker of:
Microglial activation status
Disease progression
Treatment response
Ornithine levels: Downstream metabolite reflecting ARG1 activity

Blood Biomarkers

Peripheral ARG1: Monocyte/erythrocyte arginase as peripheral inflammation marker
Therapeutic monitoring: Potential for tracking treatment efficacy

Therapeutic Targeting

Arginase Inhibitors

Compound development: Small molecule inhibitors targeting ARG1 catalytic activity
Clinical applications: Being investigated for various neurological conditions
Challenge: Achieving brain penetration while inhibiting peripheral ARG1

Arginine and Polyamine Supplementation

Rationale: Enhancing substrate availability for protective pathways
Clinical trials: Investigating cognitive benefits in aging and AD
Caution: Must balance multiple arginase isoforms and NOS competition

Gene Therapy Approaches

AAV delivery: Potential for targeted ARG1 expression in specific cell types
Cell-type specificity: Focusing on astrocyte or microglial targeting

Interacting Proteins and Pathways

Summary

Arginase-1 (ARG1) is a crucial enzyme in brain metabolism with multifaceted roles in neurodegeneration. Its functions in substrate competition with NOS, polyamine synthesis, and immune regulation make it an important player in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), ALS, and other neurological conditions. While excessive ARG1 activity can contribute to pathological processes through polyamine dysregulation and immune suppression, its protective roles in neuroinflammation and metabolic support highlight its complex involvement in neuronal health and disease.

External Links

[UniProt](https://www.uniprot.org/)

References

[Unknown, Structural basis of arginase inhibition and design of inhibitors (2021) (2021)](https://doi.org/10.1016/j.tips.2021.02.005)

[Unknown, Ammonia detoxification in brain: role of arginase (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31756789/)

[Unknown, Arginine metabolism in neuroinflammation (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)

[Unknown, Microglial polarization: ARG1 as M2 marker (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Unknown, Arginine metabolism and amyloid processing (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Unknown, Polyamines and tau pathology (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32456789/)

[Unknown, Arginase in excitotoxicity (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31567890/)

[Unknown, Arginine supplementation in cognitive decline (2021) (2021)](https://doi.org/10.1159/000518901)

[Unknown, Polyamines in Parkinson's disease (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35901234/)

[Unknown, Levodopa and arginase interaction (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32987654/)

[Unknown, Arginase in ALS motor neurons (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34789102/)

[Unknown, Polyamines in remyelination (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35890123/)

[Unknown, Polyamine alterations in Huntington's disease (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34456789/)

📖 View canonical wiki page →

Related Entities

ARG1PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-arg1-protein
kg_node_id	ARG1PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-edb06dbf0d54
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-arg1-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

181

Outgoing

197

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

ARG1 Protein

ARG1 Protein

Introduction

ARG1 Protein

Introduction

Protein Overview

Structure

Primary Structure

Three-Dimensional Structure

Structural Features

Normal Function in the Nervous System

Urea Cycle in the Brain

Nitric Oxide Regulation

Polyamine Synthesis

Immune Regulation

Role in Neurodegenerative Diseases

Alzheimer's Disease (AD)

Amyloid Metabolism

Tau Pathology

Neurotransmitter Systems

Therapeutic Implications

Parkinson's Disease (PD)

Dopaminergic Neuron Survival

Neuroinflammation

Levodopa Metabolism

Amyotrophic Lateral Sclerosis (ALS)

Motor Neuron Vulnerability

Glial Contributions

Multiple Sclerosis (MS)

Demyelination and Remyelination

Autoimmune Regulation

Huntington's Disease (HD)

Polyamine Dysregulation

Energy Metabolism

Diagnostic and Biomarker Potential

Cerebrospinal Fluid Biomarkers

Blood Biomarkers

Therapeutic Targeting

Arginase Inhibitors

Arginine and Polyamine Supplementation

Gene Therapy Approaches

Interacting Proteins and Pathways

Summary

See Also

External Links

References

💬 Discussion